Last updated on February 2018

Evaluation of the Discontinuation of Maintenance Corticosteroid Treatment in Quiescent Systemic Lupus


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
  • Age: Between 18 - 75 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patients with SLE according to the ACR revised criteria.
  • Quiescent disease without flare since at least one year (SELENA SLEDAI < or equal to 4, BILAG C, D or E, PGA 0) _ Treatment with 5 milligrams/day of prednisone since at least 1 year

Exclusion Criteria:

  • failure to sign the informed consent or unable to consent
  • Patient participating to another clinical trial
  • Pregnancy or plan to become pregnant

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.